LPL Financial LLC Buys 142,290 Shares of Sanofi (NASDAQ:SNY)

LPL Financial LLC lifted its stake in shares of Sanofi (NASDAQ:SNY) by 12.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,284,096 shares of the company’s stock after purchasing an additional 142,290 shares during the quarter. LPL Financial LLC owned 0.05% of Sanofi worth $61,932,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Guardian Partners Inc. bought a new stake in Sanofi during the 4th quarter worth approximately $9,162,000. Sei Investments Co. increased its holdings in shares of Sanofi by 8.0% in the fourth quarter. Sei Investments Co. now owns 644,302 shares of the company’s stock worth $31,075,000 after purchasing an additional 47,801 shares during the period. American Century Companies Inc. raised its position in shares of Sanofi by 1.8% in the fourth quarter. American Century Companies Inc. now owns 1,707,057 shares of the company’s stock worth $82,331,000 after buying an additional 29,536 shares in the last quarter. Lee Danner & Bass Inc. bought a new stake in Sanofi during the fourth quarter valued at $31,000. Finally, DCF Advisers LLC grew its position in Sanofi by 31.8% during the fourth quarter. DCF Advisers LLC now owns 14,500 shares of the company’s stock worth $699,000 after buying an additional 3,500 shares in the last quarter. Hedge funds and other institutional investors own 14.04% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on SNY shares. Sanford C. Bernstein raised Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. The Goldman Sachs Group assumed coverage on shares of Sanofi in a report on Friday, March 21st. They issued a “neutral” rating and a $65.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Three research analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $62.50.

Sanofi Stock Down 1.7 %

Shares of SNY opened at $54.50 on Thursday. The firm has a market cap of $138.31 billion, a P/E ratio of 21.89, a P/E/G ratio of 1.01 and a beta of 0.58. Sanofi has a 1 year low of $45.22 and a 1 year high of $60.12. The stock has a 50 day simple moving average of $54.94 and a two-hundred day simple moving average of $52.83. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. On average, analysts forecast that Sanofi will post 4.36 earnings per share for the current fiscal year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.